The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Beyond Chloroquine: Implications of Drug Resistance for Evaluating Malaria Therapy Efficacy and Treatment Policy in Africa
Abstract
Emphasis on retaining chloroquine as the first-line therapy for Plasmodium falciparum infections in most of sub-Saharan Africa for as long as it remains effective has resulted in widespread reliance on chloroquine in areas where it can have little effect on P. falciparum parasitemia. To address this issue, clinical, parasitologic, and hematologic responses to chloroquine or pyrimethamine/sulfadoxine treatment were assessed among very young children in Malawi (n = 153) and Kenya (n = 73). The median time to resumption of clinical symptoms in chloroquine-treated children was 13.5 days in Malawi and 9.5 days in Kenya. Children treated with pyrimethamine/sulfadoxine maintained clinical improvement and had greater increases in their hemoglobin concentration during the follow-up period than did children treated with chloroquine. Treatment with chloroquine failed to produce either a durable clinical improvement or optimal hematologic recovery. Consequently, chloroquine can no longer be considered adequately effective therapy of clinical P. falciparum malaria in very young children in these areas of Africa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Asymptomatic malaria infections — Do they matter?
Greenwood, B. M. (1987) · Parasitology Today · doi:10.1016/0169-4758(87)90061-5 · Cited by 122
Pricing, distribution, and use of antimalarial drugs.
Foster, S. D. (1991) · PubMed · Cited by 112
Mount, D. L., Nahlen, B. L., Patchen, L. C., & Churchill, F. C. (1989) · Europe PMC (PubMed Central) · Cited by 90
Bradley-Moore, A. M., Greenwood, B. M., Bradley, A. K., Bartlett, A., Bidwell, D. E., Voller, A., Kirkwood, B. R., & Gilles, H. M. (1985) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1985.11811962 · Cited by 88
Combating severe malaria in African children.
Breman, J. G., & Campbell, C. C. (1988) · PubMed · Cited by 58
Self-citationPaluku, K. M., Breman, J. G., Moore, M., et al. (1988) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(88)90113-7 · Cited by 23
Cited by
Quinoline Antimalarials Mechanisms of Action and Resistance and Prospects for New Agents
Foley, M. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00012-6 · Cited by 592
White, N., Nosten, F., Looareesuwan, S., Watkins, W., Marsh, K., Snow, R., Kokwaro, G., Ouma, J., Hien, T., Molyneux, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07367-x · Cited by 543
Kublin, J. G., Dzinjalamala, F. K., Kamwendo, D. D., Malkin, E. M., Cortese, J. F., Martino, L. M., Mukadam, R. A. G., Rogerson, S. J., Lescano, A. G., Molyneux, M. E., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/338566 · Cited by 523
The public health impact of chloroquine resistance in Africa
Trape, J. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.12 · Cited by 521
Kublin, J. G., Cortese, J. F., Njunju, E. M., G. Mukadam, R. A., Wirima, J. J., Kazembe, P. N., Djimdé, A. A., Kouriba, B., Taylor, T. E., & Plowe, C. V. (2003) · The Journal of Infectious Diseases · doi:10.1086/375419 · Cited by 508
Self-citationMiller, L. H., Good, M. F., & Milon, G. (1994) · Science · doi:10.1126/science.8009217 · Cited by 468
Impact of chloroquine resistance on malaria mortality
Trape, J.-F., Pison, G., Preziosi, M.-P., Enel, C., du Loû, A. D., Delaunay, V., Samb, B., Lagarde, E., Molez, J.-F., & Simondon, F. (1998) · Comptes Rendus de l'Académie des Sciences - Series III - Sciences de la Vie · doi:10.1016/s0764-4469(98)80009-7 · Cited by 452
Return of Chloroquine Antimalarial Efficacy in Malawi
Laufer, M. K., Thesing, P. C., Eddington, N. D., Masonga, R., Dzinjalamala, F. K., Takala, S. L., Taylor, T. E., & Plowe, C. V. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062032 · Cited by 432
Plowe, C. V., Cortese, J. F., Djimde, A., Nwanyanwu, O. C., Watkins, W. M., Winstanley, P. A., Estrada‐Franco, J. G., Mollinedo, R. E., Avila, J. C., Cespedes, J. L., et al. (1997) · The Journal of Infectious Diseases · doi:10.1086/514159 · Cited by 414
Factors contributing to anemia after uncomplicated falciparum malaria.
Price, R. N., Simpson, J. A., Nosten, F., Luxemburger, C., Hkirjaroen, L., ter Kuile, F., Chongsuphajaisiddhi, T., & White, N. J. (2001) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.2001.65.614 · Cited by 404
Parise, M. E., Ayisi, J. G., Nahlen, B. L., Schultz, L. J., Roberts, J. M., Misore, A., Muga, R., Oloo, A. J., & Steketee, R. W. (1998) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.1998.59.813 · Cited by 388
Self-citationRational Approaches to Improving Selectivity in Drug Design
Huggins, D. J., Sherman, W., & Tidor, B. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2010332 · Cited by 367
Guerin, P. J., Olliaro, P., Nosten, F., Druilhe, P., Laxminarayan, R., Binka, F., Kilama, W. L., Ford, N., & White, N. J. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00372-9 · Cited by 357
Newton, C. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00008-4 · Cited by 348
History, Dynamics, and Public Health Importance of Malaria Parasite Resistance
Talisuna, A. O., Bloland, P., & D’Alessandro, U. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.235-254.2004 · Cited by 322
Self-citationPharmacokinetics of Quinine, Chloroquine and Amodiaquine: Clinical Implications
Krishna, S., & White, N. J. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630040-00002 · Cited by 304
(1972) · Medicinal Chemistry · doi:10.1016/b978-0-12-688950-5.50009-x · Cited by 301
Clinical Pharmacokinetics and Metabolism of Chloroquine: Focus on Recent Advancements
Ducharme, J., & Farinotti, R. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631040-00003 · Cited by 289
CRAWLEY, J. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.25 · Cited by 260
Preventing antimalarial drug resistance through combinations
White, N. J. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80208-2 · Cited by 259
Nzila, A. M., Mberu, E. K., Sulo, J., Dayo, H., Winstanley, P. A., Sibley, C. H., & Watkins, W. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.991-996.2000 · Cited by 232
Njagi, J. K., Magnussen, P., Estambale, B., Ouma, J., & Mugo, B. (2003) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(03)90141-6 · Cited by 78
Challis, K., Osman, N. B., Cotiro, M., Nordahl, G., Dgedge, M., & Bergström, S. (2004) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2004.01307.x · Cited by 58
“Chloroquine (CQ) resistance is at 30–50% in Mozambique and surrounding countries (Schwalbach et al. 1985; Schapira & Da Costa 1988; Bloland et al. 1993; Schultz et al. 1994; Steketee et al. 1996c; Mayor et al. 2001).”
Background
Metadata
- Authors
- Bloland, P. B., Lackritz, E. M., Kazembe, P. N., Were, J. B. O., Steketee, R., & Campbell, C. C.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1993-04-01
- Volume
- 167
- Issue
- 4
- Pages
- 932-937
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W1971729111
- Cited by
- 287
- References
- 6
- FWCI
- 17.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.